Mitesh Borad, MD

Dr. Borad is currently an Associate Professor of Medicine at Mayo Clinic College of Medicine and Science. He also serves as the Director of the Cancer Cell, Gene and Virus Therapy Lab, Director of the Liver and Biliary Cancer Research Program and Deputy Director, Biomarker Discovery Program at the Center for Individualized Medicine at Mayo Clinic.  Dr. Borad concurrently serves on the National Cancer Institute’s Hepatobiliary Task Force, an appointment he has held since 2011.  Prior to joining Mayo Clinic, he spent three years as a Drug Development Scholar/Genomics Medicine Scholar at the Translational Genomic Research Institute, where he worked closely with world-renowned experts, including Dr. Daniel D. Von Hoff.

Dr. Borad earned his BS in Biomedical Engineering (summa cum laude) from Boston University and his MD from the University of Medicine and Dentistry of New Jersey.  Subsequently, he obtained his internal medical training at Cedars-Sinai Medical Center and completed his Medical Oncology Fellowship at Tulane University School of Medicine.

Dr. Borad holds a Certification in Medical Oncology from the American Board of Internal Medicine and is a member of more than 20 professional organizations and committees, including presently being seated as Vice Chairman of the International Cholangiocarcinoma Research Network.  Dr. Borad has a long and distinguished list of accolades and accomplishments, such as earning a 2014 New Innovator Award from the National Institute of Health and being named 2011 Paul Calabresi Scholar in Clinical-Translational Research by Mayo Clinic.